Overview
A global pharmaceutical enterprise, managing a network of 300+ trial sites and supporting 5,000+ field representatives globally, faced scalability issues with Veeva Vault CRM, including non-compete restrictions post-2025. Fragmented data silos and inefficient HCP engagement were significantly hindering their daily operations. Halsa Global was engaged to execute a compliant migration to Salesforce Life Sciences Cloud, transforming their disjointed architecture into a unified ecosystem while ensuring data integrity and strict regulatory adherence.
The Challenge
As the organization evaluated its long-term digital strategy, the limitations of their incumbent platform presented several major roadblocks:
- Scalability Limits and Impending Restrictions The enterprise faced severe scalability issues with Veeva Vault CRM, compounded by looming non-compete restrictions post-2025 that necessitated an immediate platform shift.
- Fragmented Data and Inefficient Engagement Deeply entrenched data silos and disconnected systems resulted in inefficient HCP engagement across their global pharma operations.
- Disconnected Workflows and High Migration Risk Manual compliance checks and disconnected clinical-commercial workflows caused delays in approvals and poor visibility into trial sites. Furthermore, high migration risks threatened both data integrity and regulatory adherence during the transition.
Our Solution
Halsa Global executed a compliant migration to Salesforce Life Sciences Cloud, leveraging the native Salesforce ecosystem for a unified CRM. Veeva data was mapped to Life Sciences objects, with Agentforce automating HCP outreach and field inventory. Built-in governance, Einstein Trust Layer for HIPAA compliance, and low-code Agent Builder ensured a seamless transition without disrupting operations.
The Outcome
- 60% reduction in system silos, enabling omnichannel HCP execution.
- 45% faster approval cycles via automated workflows and real-time analytics.
- 30% cost savings from ecosystem integration, avoiding Veeva licensing hikes.
Conclusion
Through its partnership with Halsa Global, the enterprise successfully navigated the complex migration from Veeva to Salesforce Life Sciences Cloud. By seamlessly mapping legacy data and deploying intelligent automation, the organization eliminated critical system silos, accelerated approval cycles, and established a scalable, HIPAA-compliant foundation for global operations.